This is a 12-month training program for clinicians and other professionals that provides a foundational understanding of the literature and practice of psychedelic-assisted psychotherapy, including the use of ketamine, MDMA, and psilocybin in therapeutic settings. This program is designed for clinicians—especially psychotherapists, physicians, and others, but being a clinician is not a requirement for acceptance.
Read More
The “journey,” in this instance, is brought on by ketamine, administered intravenously, as a treatment for mental health disorders, albeit one that has not yet been approved by the Food and Drug Administration.
Read More
Tripping's not just for deadheads anymore: Philly parents — and lots of other people — are learning that the secret to health, happiness, and healing might just come from some formerly far-out drugs.
Like most working parents, Marissa has a lot to juggle — kids, her job as a nutritionist, her home outside of Philadelphia. And then there are the in-laws.
The Philadelphia Inquirer wrote about SoundMind and interviewed our founder Dr. Hannah McLane. You can read some highlights in this post.
Read More
Research into psychedelic-assisted therapy has grown in the past ten years as non-profits, academic institutions, pharmaceutical companies, and even venture capitalists race to develop protocols for using MDMA, psilocybin, ketamine, and other psychedelic substances to treat mental illness. Already, dozens of ketamine clinics across the country administer the medication off-label for depression, and MDMA- and psilocybin-assisted therapy are expected to be approved by the FDA in the coming years.
Read More
You’re lying on a bed in a dimly–lit room. Music surrounds you, and the air is soft on your skin. You slip a lozenge under your tongue. As it dissolves, you close your eyes, settling in for the experience ahead. Sitting beside you, a therapist offers a reassuring presence. If anxiety sets in, you’re prepared: deep breath in, then out. Slowly you ease into an altered state of consciousness as visions, memories, and visceral sensations wash over you in waves. Your journey begins.
Read other highlights from the article in this blog post.
Read More
This September, SoundMind joined state leaders, community advocates, and other key stakeholders in Lancaster for the PA Latino Convention, an annual gathering focused on championing the needs of the state’s rapidly expanding Latinx community. Pennsylvania’s Latinx population has more than doubled in the last 20 years—to nearly one million residents—and is home to the second largest migration of Puerto Ricans following Hurricane Maria.
Read More
The Temple News published an article about SoundMind and Hannah McLane, Temple University alumna. Read some highlights in this post.
Read More
Philadelphia Magazine featured SoundMind and our founder Dr. Hannah McLane in a Q&A on psychedelic medicine in Philly! Some highlights from the interview are in the post.
Read More
On August 1, SoundMind opened its doors at 4623 Spruce Street, announcing its launch as the first psychedelic-assisted therapy clinic in Philadelphia, and the first on the east coast to center the needs of marginalized patients. To celebrate our opening, we hosted a launch party and fundraising event with guests from the local community and across the country!
Read More